{
  "kind": "treatment",
  "slug": "piracetam",
  "type": "medication",
  "name": "Piracetam",
  "summary": "Piracetam is a nootropic compound of the racetam family, used primarily to enhance cognitive function and, in some countries, to treat neurological disorders such as dementia, cognitive decline, and myoclonus.",
  "description": "Piracetam is a cyclic derivative of gamma-aminobutyric acid (GABA) but does not act directly on GABA receptors. Instead, it is thought to modulate neurotransmission, enhance neuronal membrane fluidity, and improve microcirculation in the brain. It has been studied for use in cognitive impairment, Alzheimer's disease, stroke recovery, and myoclonus. Although widely used in some countries, piracetam is not FDA-approved in the United States and is considered a supplement or research chemical there.",
  "category": "medications/nootropics",
  "tags": [
    "nootropic",
    "cognitive enhancer",
    "neuroprotective",
    "racetam"
  ],
  "metadata": {
    "drug_classes": [
      "Nootropic",
      "Racetam"
    ],
    "therapeutic_categories": [
      "Neurology",
      "Geriatrics"
    ],
    "mechanism_categories": [
      "Other"
    ],
    "administration_routes": [
      "Oral",
      "Injection"
    ],
    "prescription_status": "Varies by country",
    "controlled_substance": false,
    "generic_available": true,
    "brand_names": [
      "Nootropil",
      "Lucetam"
    ],
    "age_groups": [
      "Adult",
      "Geriatric"
    ],
    "treatment_duration": [
      "Short-term",
      "Chronic"
    ],
    "specialty_areas": [
      "Neurology",
      "Psychiatry"
    ],
    "fda_approval_year": 1971
  },
  "clinical_metadata": {
    "primary_indications": [
      "Dementia",
      "Other"
    ],
    "off_label_uses": [
      "Learning and memory enhancement in healthy individuals",
      "Vertigo",
      "Sickle cell vaso-occlusive crisis prevention"
    ],
    "contraindications": [
      "Severe renal impairment",
      "Cerebral hemorrhage",
      "Hypersensitivity to piracetam or other racetams"
    ],
    "monitoring_required": [
      "Renal function",
      "Response in cognitive and neurological status"
    ],
    "efficacy_rating": {
      "Cognitive decline": 2,
      "Myoclonus": 3
    }
  },
  "search_metadata": {
    "searchable_terms": [
      "piracetam",
      "Nootropil",
      "racetam nootropic",
      "cognitive enhancer"
    ],
    "synonyms": [
      "Nootropil",
      "Lucetam"
    ],
    "common_misspellings": [
      "piracetan",
      "piracetum"
    ]
  },
  "sections": [
    {
      "type": "indications",
      "items": [
        "Treatment of cortical myoclonus",
        "Adjunctive therapy in cognitive impairment and dementia",
        "Supportive therapy in post-stroke recovery"
      ]
    },
    {
      "type": "mechanism",
      "text": "Piracetam modulates neurotransmission by influencing ion channels and carriers, enhancing neuronal membrane fluidity, and increasing oxygen and glucose utilization in the brain."
    },
    {
      "type": "dosing",
      "adult": {
        "Cognitive disorders": "2.4â€“4.8 g/day orally in divided doses",
        "Myoclonus": "Start at 7.2 g/day orally in divided doses; may increase to 24 g/day"
      },
      "pediatric": {
        "text": "Not routinely used; safety not well established"
      },
      "geriatric": "Dose adjustment may be necessary for renal impairment"
    },
    {
      "type": "dosage_forms",
      "items": [
        "Oral tablets",
        "Oral solution",
        "Intravenous injection (in some regions)"
      ]
    },
    {
      "type": "onset_duration",
      "text": "Onset: May require days to weeks for cognitive effects; Duration: effects maintained with continued dosing"
    },
    {
      "type": "adverse_effects",
      "common": [
        "nervousness",
        "weight gain",
        "somnolence"
      ],
      "less_common": [
        "insomnia",
        "anxiety",
        "depression"
      ],
      "serious": [
        "worsening of myoclonus in some patients",
        "bleeding risk"
      ]
    },
    {
      "type": "warnings",
      "other": [
        "Adjust dose in renal impairment",
        "Avoid abrupt discontinuation in myoclonus due to risk of symptom rebound"
      ]
    },
    {
      "type": "interactions",
      "items": [
        {
          "with": "Thyroid hormones",
          "risk": "Confusion, irritability, sleep disturbance",
          "action": "Monitor closely"
        },
        {
          "with": "Anticoagulants",
          "risk": "Increased bleeding risk",
          "action": "Monitor coagulation parameters"
        }
      ]
    },
    {
      "type": "monitoring",
      "items": [
        "Renal function before and during therapy",
        "Neurological status",
        "Bleeding signs in high-risk patients"
      ]
    },
    {
      "type": "special_populations",
      "pregnancy": "Use only if potential benefits outweigh risks; insufficient human data",
      "lactation": "Unknown if excreted in breast milk; caution advised",
      "geriatrics": "Renal dosing adjustments required"
    },
    {
      "type": "tapering",
      "text": "Gradual dose reduction recommended in patients with myoclonus to prevent rebound symptoms"
    },
    {
      "type": "clinical_notes",
      "items": [
        "Efficacy in healthy individuals for cognitive enhancement remains controversial",
        "Popular in nootropic communities despite limited regulatory approval in some countries",
        "Has a favorable safety profile but requires caution in renal impairment"
      ]
    },
    {
      "type": "references",
      "items": [
        {
          "label": "Drugs.com - Piracetam",
          "url": "https://www.drugs.com/international/piracetam.html"
        },
        {
          "label": "MedlinePlus - Piracetam",
          "url": "https://medlineplus.gov/druginfo/meds/a682077.html"
        }
      ]
    }
  ],
  "seo": {
    "title": "Piracetam - Nootropic for Cognitive and Neurological Conditions",
    "description": "Piracetam is a racetam nootropic used for cognitive impairment, dementia, and myoclonus. Learn about uses, dosing, safety, and mechanisms."
  }
}
